StockData
ArriVent BioPharma, Inc. logo

ArriVent BioPharma, Inc. (AVBP) stock

AVBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$13.01−0.06 (-0.46%)

Close on Nov 13, 2026Market cap $641.49MP/E –Yield –

ArriVent BioPharma statistics

56 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 4, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$641.49M
$272.32M
Enterprise Value
$248.27M
$146.23M
PB Ratio
1.63
2.00
P/TBV Ratio
1.63
2.22

Share statisticsIndustry

Shares Change (YoY)
28.1%
10.8%
Shares Change (QoQ)
5.99%
0.50%
Float
45M
49M
Shares Held by Insiders
8.55%
11.7%
Shares Held by Institutions
93.5%
56.4%

Short sellingIndustry

Short Interest
6M
–
Short Interest Change
-14.8%
-0.80%
Short % of Float
12.9%
9.01%
Short % of Shares Outstanding
11.8%
6.30%
Days to Cover
3.43
5.15

Stock price statisticsIndustry

52-Week High
$35.83
–
52-Week Low
$11.36
–
20-Day Moving Average
$15.32
–
50-Day Moving Average
$21.36
–
200-Day Moving Average
$26.48
–
Average True Range (14)
$1.47
–
Price Change (1 Week)
-4.62%
-1.15%
Price Change (1 Month)
-22.5%
-4.87%
Price Change (3 Months)
-55.2%
-21.0%
Price Change (6 Months)
-53.3%
-20.6%
Price Change (YTD)
-35.3%
-23.6%
Price Change (1 Year)
-35.6%
-22.4%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
1M
–
Relative Volume
0.58
0.70
Relative Strength Index (14)
34.1
43.4
Volatility (1 Year)
81.4%
80.1%
Beta (5 Years)
0.99
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-48.4%
-49.9%
Return on Assets (ROA)
-45.5%
-40.6%
Return on Invested Capital (ROIC)
-5738.0%
-32.9%

EfficiencyIndustry

Profits Per Employee
-$2.20M
-$689.41K
Employee Count
77
74
WACC
10.0%
10.2%

Income statement (TTM)Industry

Operating Income
-$181.00M
-$21.37M
Net Income
-$169.07M
-$22.35M
EBITDA
-$181.00M
-$17.21M
EPS (Diluted)
-$3.65
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$393.22M
$17.76M
Net Cash Per Share
$7.97
$0.80
Equity (Book Value)
$393.48M
$53.89M
Book Value Per Share
$7.98
$1.50
Tangible Book Value
$393.48M
$27.13M

Cash flow (TTM)Industry

Operating Cash Flow
-$152.84M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-26.4%
-21.8%
Buyback Yield
-36.5%
-0.76%
Shareholder Yield
-36.5%
0.00%

Scores and fair valueIndustry

Altman Z-Score
13.06
0.23
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodAVBPS&P 500DifferenceAVBP per yearS&P 500 per year
1 month-19.1%-3.0%−16.1 pts
3 months-56.6%-2.8%−53.9 pts
Year to date-35.3%+11.5%−46.8 pts
1 year-33.9%+13.5%−47.4 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

6M AVBP shares were sold short on Oct 30, 2026, down 14.8% from the previous report, or 12.86% of the shares available to trade. At recent volumes it would take 3.4 days to buy them back. Over the last 20 sessions, 47.9% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20265,797,018-14.8%1,689,4593.4
Oct 15, 20266,806,605-19.5%3,053,4892.2
Sep 30, 20268,451,472-3.6%751,30211.3
Sep 15, 20268,766,246+0.9%495,48917.7
Aug 31, 20268,691,715+5.6%425,43320.4
Aug 14, 20268,227,393+2.2%378,01521.8
Jul 31, 20268,046,475+5.0%578,05913.9
Jul 15, 20267,665,375+0.5%429,47817.9
Jun 30, 20267,624,281-2.8%842,8319.1
Jun 15, 20267,847,671+1.8%598,35913.1
May 29, 20267,709,676+5.6%534,53114.4
May 15, 20267,299,894+2.7%323,71622.6

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?